Other
minimum effective volume
minimum effective volume is an intervention with 2 clinical trials. Historical success rate of 50.0%.
Total Trials
2
Max Phase
-
Type
OTHER
Molecule
-
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
0 source entries across 0 studies. This list may not include all unresolved or historical entries.
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(50%)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
2
all time
Status Distribution
Completed(1)
Terminated(1)
Detailed Status
Terminated1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
2
Active
0
Success Rate
50.0%
Trials by Status
terminated150%
completed150%
Recent Activity
Clinical Trials (2)
Showing 2 of 2 trials
NCT03555786
MEV for Retroclavicular Approach to Infraclavicular Block
NCT03472911
Retroclavicular Approach to Infraclavicular Block
All 2 trials loaded
Drug Details
- Intervention Type
- Other
- Total Trials
- 2